3041-3050 of 4446 results
Disclosing privileged documents to regulators
The case of Cantor v Audi provides insights into what you should consider before providing privileged documents to a regulator. ...
Successor Fund Transfers - all aboard!
APRA yesterday released a draft guide on transferring a member's benefit from one superannuation fund to another without their consent. The interpretation adopted provides minimal protection to superannuation fund members. ...
The ASIC Enforcement Review Taskforce unloaded
The ASIC Enforcement Review Taskforce members and terms of reference have been announced The terms of reference are very broad and come as no surprise with an emphasis on evaluating the adequacy of ASICs enforcement toolkit We analyse the key themes that are likely to emerge ...
Finger buns get a thumbs down from Advertising Standards Board
Growing community scepticism of sugar has made its way into the Advertising Standards Board, highlighted in a recent decision brought against Bakers Delights advertising of finger buns ...
GSK-Pfizer consumer health care deal found to be painless; ACCC milks competition in dairy industry; and ACCC inquiries and investigations feature in election policies.
GSK-Pfizer consumer health care deal found to be painless; ACCC milks competition in dairy industry; and ACCC inquiries and investigations feature in election policies. ...
ASIC's 'why not litigate?' stance, ASX's Corporate Governance Roadshow and other developments
Welcome to our monthly snapshot of regulatory updates and other developments in corporate law We know you are busy so our focus is on capturing key issues ...
Compensating superannuation members for 'fees for no advice'
APRA and ASIC issued a joint letter to all RSE licensees entitled 'Oversight of fees charged to members' superannuation accounts' in early April, in response to the 'fee for no advice' issue that attracted so much attention in the Royal Commission ...
Global trade mark update
There have been significant, and proposed, trade mark law developments across the globe which are likely to inform trade mark portfolio strategy. ...
Licence to infringe: Patent Office grants Sandoz licence to exploit Lexapro® patent
In the latest chapter of one the longest-running sagas in Australian patent litigation history, the Deputy Commissioner of Patents has retrospectively granted Sandoz a licence to exploit Lundbeck's patent for its blockbuster antidepressant Lexapro® (escitalopram). The licence, only the second of its kind to be granted in Australia, provides Sandoz with a defence to Lundbeck's multi-million dollar infringement claim. ...
Lag and loss: managing the impacts of delay in project delivery
Three recent UK decisions highlight contractual mechanisms for managing aspects of risks associated with delay in project delivery Projects Partner Leighton OBrien considers the implications for projects in Australasia ...